INVO Bioscience Acquires Wisconsin Fertility Institute
March 20, 2023
INVO Bioscience, Inc. (Nasdaq: INVO) has signed binding agreements to acquire Wisconsin Fertility Institute, a Madison-area fertility clinic that generated approximately $5.5 million in trailing 12-month revenue. The purchase price is $10.0 million payable over three years, and the clinic will become a wholly owned subsidiary to expand INVO's clinic footprint and support adoption of its INVOcell technology.
- Buyers
- INVO Bioscience, Inc.
- Targets
- Wisconsin Fertility Institute
- Sellers
- Owners of Wisconsin Fertility Institute (not individually disclosed)
- Industry
- Healthcare Services
- Location
- Wisconsin, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.